Liposomal irinotecan plus chemo in the new NALIRIFOX regimen significantly improved overall survival compared with standard therapy in metastatic pancreatic ductal adenocarcinoma.
The latest American Cancer Society annual report highlights an increase in late-stage prostate cancer diagnoses, but also a dramatic fall in cervical cancer in young women.
Direct-acting antiviral therapy significantly improves liver outcomes, nonliver outcomes, and long-term survival for patients with chronic hepatitis C virus, regardless of disease stage.
Liver cancer genetics and biology differ between men and women and help explain why aflatoxin exposure increases the risk in hepatitis B virus (HBV)–infected patients, particularly in men.